VIEMED HEALTHCARE, INC. (VMD) Current Ratio
- Current ratio · latest quarter: Value 1.13×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.13× | Current assets / current liabilities. $53.97M ÷ $47.89M ≈ 1.13× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 53.97M USD | Assets, Current |
| Current obligations | 47.89M USD | Liabilities, Current |
| Cash and equivalents | 10.68M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 32.23M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 5.27M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | 717.00K USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $53.97M | $47.89M | $10.68M | (m) | $32.23M | $5.27M | (m) | $717.00K | 1.13× |
| 2026-03-31 | $49.81M | $40.71M | $9.76M | (m) | $31.18M | $5.18M | (m) | $871.00K | 1.22× |
| 2025-12-31 | $48.49M | $41.06M | $13.50M | (m) | $25.59M | $5.05M | (m) | $1.09M | 1.18× |
| 2025-09-30 | $49.98M | $44.19M | $11.12M | (m) | $27.41M | $5.27M | (m) | $1.55M | 1.13× |
| 2025-06-30 | $55.29M | $37.27M | $20.02M | (m) | $26.55M | $4.32M | (m) | $820.00K | 1.48× |
| 2025-03-31 | $49.12M | $35.49M | $10.16M | (m) | $26.79M | $4.51M | (m) | $390.00K | 1.38× |
| 2024-12-31 | $52.88M | $37.33M | $17.54M | (m) | $24.91M | $4.32M | (m) | $409.00K | 1.42× |
| 2024-09-30 | $47.70M | $36.44M | $11.35M | (m) | $27.05M | $4.31M | (m) | $812.00K | 1.31× |
| 2024-06-30 | $44.98M | $31.48M | $8.81M | (m) | $27.06M | $4.42M | (m) | $772.00K | 1.43× |
| 2024-03-31 | $38.62M | $30.12M | $7.31M | (m) | $24.48M | $4.35M | (m) | $596.00K | 1.28× |
| 2023-12-31 | $38.37M | $32.12M | $12.84M | (m) | $18.45M | $4.63M | (m) | $1.07M | 1.19× |
| 2023-09-30 | $35.86M | $31.55M | $10.08M | (m) | $17.93M | $4.67M | (m) | $1.83M | 1.14× |
| 2023-06-30 | $35.95M | $31.57M | $10.22M | (m) | $17.89M | $4.48M | (m) | $3.17M | 1.14× |
| 2023-03-31 | $46.70M | $23.42M | $23.54M | (m) | $16.32M | $3.45M | (m) | (m) | 1.99× |
| 2022-12-31 | $39.74M | $18.86M | $16.91M | (m) | $15.38M | $3.57M | (m) | $0.00 | 2.11× |
| 2022-09-30 | $42.86M | $20.56M | $21.48M | (m) | $14.98M | $3.18M | (m) | $165.00K | 2.09× |
| 2022-06-30 | $41.86M | $17.86M | $21.92M | (m) | $14.29M | $2.85M | (m) | $612.00K | 2.34× |
| 2022-03-31 | $47.80M | $17.73M | $29.25M | (m) | $13.60M | $2.50M | (m) | $1.05M | 2.70× |
| 2021-12-31 | $47.31M | $17.81M | $28.41M | (m) | $12.82M | $2.46M | (m) | $1.48M | 2.66× |
| 2021-09-30 | $47.37M | $20.20M | $26.87M | (m) | $12.70M | $2.62M | (m) | $1.91M | 2.34× |
| 2021-06-30 | $47.05M | $18.32M | $31.15M | (m) | $12.13M | $2.56M | (m) | $1.88M | 2.57× |
| 2021-03-31 | $48.27M | $21.86M | $31.10M | (m) | $13.28M | $2.22M | (m) | $1.86M | 2.21× |
| 2020-12-31 | $47.17M | $23.02M | $30.98M | (m) | $12.37M | $2.31M | (m) | $1.84M | 2.05× |
| 2020-09-30 | $49.98M | $30.35M | $32.40M | (m) | $11.49M | $2.76M | (m) | $1.81M | 1.65× |
| 2020-06-30 | $49.21M | $31.77M | $29.71M | (m) | $11.03M | $6.58M | (m) | $1.79M | 1.55× |
| 2020-03-31 | $30.15M | $26.15M | $8.41M | (m) | $15.44M | $1.78M | (m) | $1.77M | 1.15× |
| 2019-12-31 | $27.81M | $25.91M | $13.36M | (m) | $11.53M | $1.36M | (m) | $1.75M | 1.07× |
| 2019-09-30 | $27.80M | $26.55M | $12.63M | (m) | $11.73M | $1.27M | (m) | $1.73M | 1.05× |
| 2019-06-30 | $25.19M | $27.39M | $7.69M | (m) | $12.80M | $3.71M | (m) | $133.00K | 0.92× |
| 2019-03-31 | $23.75M | $21.68M | $7.41M | (m) | $11.67M | $3.62M | (m) | $0.00 | 1.10× |
| 2018-12-31 | $23.09M | $19.57M | $10.41M | (m) | $8.84M | $2.89M | (m) | $0.00 | 1.18× |
| 2018-09-30 | $21.99M | $17.19M | $10.17M | (m) | $8.39M | $2.38M | (m) | $0.00 | 1.28× |
| 2018-06-30 | $18.92M | $15.46M | $8.55M | (m) | $7.86M | $1.94M | (m) | $0.00 | 1.22× |
| 2018-03-31 | $17.93M | $14.61M | $4.63M | (m) | $10.69M | $1.96M | (m) | $0.00 | 1.23× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |